Drug therapy of trigeminal neuralgia

References

• Canavero S, Bonicalzi V, Pagni CA. The riddle of trigeminal neuralgia. Pain 60, 229–231 (1995).
   PubMed Web of Science ®Google Scholar
• Canavero S, Bonicalzi V, Ferroli P. Can trauma alone to the trigeminal root relieve trigeminal neuralgia? The case against the microvascular compression hypothesis. J. Neurol. Neurosurg. Psychiatry 63, 411–412 (1997).
   PubMed Web of Science ®Google Scholar
• Bonicalzi V, Canavero S. Role of microvascular decompression in trigeminal neuralgia. Lancet 355, 928–929 (2000).
   PubMedGoogle Scholar
• Bonicalzi V, Canavero S. A case of trigeminal–vagal neuralgia relieved by peripheral self-stimulation. Acta Neurol. Belg. 102, 188–190 (2002).
   PubMed Web of Science ®Google Scholar
• Rovit R. Commentary. In: Surgical Management of Pain. Burchiel KJ (Ed.). Thieme, NY, USA, 301–303 (2002).
   Google Scholar
• Zakrzewska JM, Lopez BC. Trigeminal neuralgia. Clin. Evid. 12, 1880–1890 (2004).
   Google Scholar
• Cheshire WP. Trigeminal neuralgia. A guide to drug choice. CNS Drugs 7, 98–110 (1997).
   PubMed Web of Science ®Google Scholar
• Taylor JC, Brauer S, Espir MLE. Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad. Med. J. 57, 16–18 (1981).
   PubMed Web of Science ®Google Scholar
• Fromm GH, Nakata M, Kondo T. Differential action of amitriptyline on neurons in the trigeminal nucleus. Neurology 41, 1932–1936 (1991).
   PubMed Web of Science ®Google Scholar
• Leander JD. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine and ameltolide (LY201116). Epilepsia 33, 573–576 (1992).
   PubMed Web of Science ®Google Scholar
• Strittmatter M, Grauer M, Isenberg E et al. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache 37, 211–216 (1997).
   PubMed Web of Science ®Google Scholar
• Stajcic Z, Juniper RP, Todorovic L. Peripheral streptomycine/lidocaine injections versus lidocaine alone in the treatment of idiopathic trigeminal neuralgia. A double blind controlled study. J. Craniomaxillofacial Surg. 18, 243–246 (1990).
   PubMed Web of Science ®Google Scholar
• Spacek A, Neiger FX, Orlicek F et al. Ganglionic local opioid analgesia (GLOA) as well as saline injection reduces pain in trigeminal neuralgia. In: World Congress on Pain, Book of Abstracts. IASP Press, Seattle, WA, USA, A133 (1999).
   Google Scholar
• Day M. Sphenopalatine ganglion analgesia. Curr. Rev. Pain 3, 342–347 (1999).
   PubMedGoogle Scholar
• Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD. An open study of botulinum-A toxin of trigeminal neuralgia. Neurology 65, 1306–1308 (2005).
   PubMed Web of Science ®Google Scholar
• Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J. Pain 3, 21–27 (2002).
   PubMed Web of Science ®Google Scholar
• Micheli F, Scorticati MC, Raina G. Beneficial effects of botulinum toxin type A for patients with painful tic convulsive. Clin. Neuropharmacol. 25, 260–262 (2002).
   PubMed Web of Science ®Google Scholar
• Kugelberg L, Choi YK, Liu J. The use of 5% lidocaine for prolonged analgesia in chronic pain patients: a new technique. Reg. Anesth. Pain Med. 23, 96–100 (1998).
   PubMed Web of Science ®Google Scholar
• Canavero S, Bonicalzi V. Intravenous subhypnotic propofol in central pain. A double-blind, placebo-controlled, cross-over study. Clin. Neuropharmacol. 27, 182–186 (2004).
   PubMed Web of Science ®Google Scholar
• Burchiel KJ. In: Surgical Management of Pain. Thieme, NY, USA, 326 (2002).
   Google Scholar
• Fromm GH, Chatta AS, Terrence CF, Glass JD. Role of inhibitory mechanisms in trigeminal neuralgia. Neurology 31, 683–687 (1981).
   PubMed Web of Science ®Google Scholar
• Canavero S, Bonicalzi V. Therapeutic extradural cortical stimulation for central and neuropathic pain: a review. Clin. J. Pain 18, 48–55 (2002).
   Google Scholar
• Canavero S, Bonicalzi V. Neuromodulation for central pain. Expert Rev. Neurotherapeutics 3, 591–607 (2003).
   PubMedGoogle Scholar
• Thorsen SW, Lumsden SG. Trigeminal neuralgia: sudden and long-term remission with TENS. J. Manipulative Physiol. Ther. 20, 415–419 (1997).
   PubMed Web of Science ®Google Scholar
• Wilkins RH. Trigeminal neuralgia: historical overview, with emphasis on surgical treatment. In: Surgical Management of Pain. Burchiel KJ (Ed.). New York, Thieme, 288–301 (2002).
   Google Scholar
• Campbell FG, Graham JG, Zilkha KJ. Clinical trial of Carbazepine (Tegretol) in trigeminal neuralgia. J. Neurol. Neurosur. Psych. 29, 265–267 1966.
   Google Scholar
• Rockliff BW, Davis EH. Controlled sequential trials of Carbamazepine in trigeminal neuralgia. Arch. Neurol. 15, 129–136 1966.
   Google Scholar
• Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch. Neurol. 19, 129–136 (1968).
   PubMed Web of Science ®Google Scholar
• Nicol CF. A four year double blind study of tegretol in facial pain. Headache 9, 54–57 (1969).
   PubMedGoogle Scholar
• Vilming ST, Lyberg T, Lataste X. Tizanidine in the management of trigeminal neuralgia. Cephalagia 6, 181–182 (1986).
   PubMed Web of Science ®Google Scholar
• Lindstrom P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 28, 45–50 (1989).
   Web of Science ®Google Scholar
• Lechin F, van der Dijs B, Lechin ME et al. Pimozide therapy for trigeminal neuralgia. Arch. Neurol. 46, 960–963 (1987).
   Google Scholar
• Carasso RL, Yehuda S, Streier M. Clomipramine and amitriptyline in the treatment of severe pain. Int. J. Neuroscience 9, 191–194 (1979).
   PubMed Web of Science ®Google Scholar
• Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann. Neurol. 15, 240–244 (1984).
   PubMed Web of Science ®Google Scholar
• Fromm GH, Terrence CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 37(11), 1725–1728 (1987).
   PubMed Web of Science ®Google Scholar
• Fromm GH, Aumentado D, Terrence CF. A clinical and experimental investigation of the effects of tizanidine in trigeminal nevralgia. Pain 53, 265–271 (1993).
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results for a double blind placebo controlled crossover trial. Pain 73, 223–230 (1997).
   PubMed Web of Science ®Google Scholar
• Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin. Neuropharmacol. 24(2), 109–112 (2001).
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Lemley T, Kestle JR, Lunsford LD, Fromm GH, Jannetta PJ. The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial. J. Neurosurg. 80(6), 993–937 (1994).
   PubMed Web of Science ®Google Scholar
• Spillane JD. The treatment of trigeminal neuralgia: preliminary experience with 'tegretol'. The Practitioner 192, 71–77 (1964).
   PubMedGoogle Scholar
• Iannone A, Baker AB, Morrell F. Dilantin in the treatment of trigeminal neuralgia. Neurology 8, 126–128 (1958).
   PubMed Web of Science ®Google Scholar
• Braham J, Saia A. Phenytoin in the treatment of trigeminal and other neuralgias. Lancet 2, 892–893 (1960).
   Web of Science ®Google Scholar
• Chinitz A, Seelinger DF, Greenhouse AH. Anticonvulsant therapy in trigeminal neuralgia. Am. J. Med. Sci. 252, 62–67 (1966).
   PubMed Web of Science ®Google Scholar
• Kugelberg E, Lindblom U. The mechanism of the pain in trigeminal neuralgia. J. Neurol. Neurosurg. Psych. 22, 36–43 (1959).
   PubMed Web of Science ®Google Scholar
• Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J. Pain Symptom Manage. 21(6), 506–510 (2001).
   PubMed Web of Science ®Google Scholar
• Galer BS, Miller KV, Rowbotham MC. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology 43, 1233–1235 (1993).
   PubMed Web of Science ®Google Scholar
• Court JE, Kase CS. Treatment of tic douloureux with a new anticonvulsant (clonazepam). J. Neurol. Neurosurg. Psych. 39, 297–299 (1976).
   PubMed Web of Science ®Google Scholar
• Chandra B. The use of clonazepam in the treatment of tic douloureux (a preliminary report). Proc. Aust. Assoc. Neurol. 13, 119–122 (1976).
   PubMedGoogle Scholar
• Peiris JB, Perera GL, Devendra SV, Lionel ND. Sodium valproate in trigeminal neuralgia. Med. J. Aust. 2, 278 (1980).
   PubMed Web of Science ®Google Scholar
• Tomson T, Bertilsson L. Potent therapeutic effect of carbamazepine-10, 11-epoxide in trigeminal neuralgia. Arch. Neurol. 41(6), 598–601 (1984).
   PubMedGoogle Scholar
• Tomson T, Tybring G, Bertilsson L, Ekbom K, Rane A. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. Arch. Neurol. 37, 699–703 (1980).
   PubMedGoogle Scholar
• Zakrzewska JM, Patsalos PN. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J. Neurol. Neurosurg. Psych. 52, 472–476 (1989).
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 95(3), 259–266 (2002).
   PubMed Web of Science ®Google Scholar
• Pascual J, Berciano J. Failure of mexiletine to control trigeminal neuralgia. Headache 29, 517–518 (1989).
   PubMed Web of Science ®Google Scholar
• Reder AT, Arnason BG. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology 45(6), 1097–1100 (1995).
   PubMed Web of Science ®Google Scholar
• DMKG study group. Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J. Neurol. 250(5), 542–545 (2003).
   PubMed Web of Science ®Google Scholar
• Canavero S, Bonicalzi V, Ferroli P, Zeme S, Montalenti E, Benna P. Lamotrigine control of idiopathic trigeminal neuralgia. J. Neurol. Neurosurg. Psych. 59(6), 646 (1995).
   PubMed Web of Science ®Google Scholar
• Canavero S, Bonicalzi V. Lamotrigine control of trigeminal neuralgia: an expanded study. J. Neurol. 244(8), 527 (1997).
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Lopez BC. Trigeminal neuralgia. Clin. Evid. (12), 1880–1890 (2004).
   PubMedGoogle Scholar
• de Negrotto OV, Dalmas JF, Negrotto A. Trigeminal neuralgia. Treatment with clonazepam. Acta. Neurol. Latinoam. 20(1–4), 139–145 (1974).
   PubMedGoogle Scholar
• Caccia MR. Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study. Eur. Neurol. 13(6), 560–563 (1975).
   PubMed Web of Science ®Google Scholar
• Smirne S, Scarlato G. Clonazepam in cranial neuralgias. Med. J. Aust. 1(4), 93–94 (1977).
   PubMed Web of Science ®Google Scholar
• Smirne S, Sinatra MG. Clonazepam in painful syndromes of the head. Riv. Neurol. 49(2), 140–150 (1979).
   PubMedGoogle Scholar
• Taylor J. Trigeminal neuralgia treated with carbamazepine. J. Neurol. Neurosurg. Psych. 26, 553–554 (1963).
   Google Scholar
• Dalessio DJ, Abbott K. A new agent in the treatment of tic douloureux: a preliminary report. Headache 5, 103–107 (1966).
   PubMedGoogle Scholar
• Javid M, Dardenne G. Evaluation of carbamazepine in the management of tic douloureux and other painful disorders. Wis. Med. J. 68, 95–101 (1969).
   PubMedGoogle Scholar
• Rasmussen P, Riischiede J. Facial pain treated with carbamazepin (Tegretol). Acta. Neurol. Scand. 46, 385–408 (1970).
   PubMed Web of Science ®Google Scholar
• Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). Lancet 1, 839–840 (1962).
   PubMed Web of Science ®Google Scholar
• Blom S. Tic douloureux treated with new anticonvulsant. Arch. Neurol. 9, 285–290 (1963).
   PubMed Web of Science ®Google Scholar
• Karlov VA, Savitskaya O. Comparative effectiveness of antiepileptic preparations in the treatment of patients with trigeminal neuralgia. Zh. Nevropatol. Psikhiatr. 80, 530–535 (1980).
   Google Scholar
• Lemoyne J. Essential facial neuralgia therapy with dimethyl-dithio-hydantoin. Concours Med. 73, 461–463 (1951).
   PubMedGoogle Scholar
• Jensen H. Therapy of trigeminal neuralgia with diphenylhydantoin. Aerztl. Wschr. 9, 105–108 (1954).
   Google Scholar
• Albert HH. Infusion therapy of acute trigeminal neuralgia using phenytoin i.v. MMW Munch. Med. Wochenschr. 120(15), 529–530 (1978).
   PubMedGoogle Scholar
• Merren MD. Gabapentin for treatment of pain and tremor: a large case series. South Med. J. 91, 739–744 (1998).
   PubMed Web of Science ®Google Scholar
• Lindstrom P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 28, 45–50 (1987).
   PubMed Web of Science ®Google Scholar
• Lunardi G, Leandri M, Albano C et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48(6), 1714–1717 (1997).
   PubMed Web of Science ®Google Scholar
• Leandri G, Leandri M, Albano C et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J. Neurol. 247(7), 556–558 (2000).
   PubMed Web of Science ®Google Scholar
• Cheshire WP. Felbamate relieved trigeminal neuralgia. Clin. J. Pain 139, 42 (1995).
   Google Scholar
• Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology 48(5), 1467 (1997).
   PubMed Web of Science ®Google Scholar
• Solaro C, Lunardi GL, Capello E et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 51, 609–611 (1998).
   PubMed Web of Science ®Google Scholar
• Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51(2), 611–614 (1998).
   PubMed Web of Science ®Google Scholar
• Valzania Strafella P, Nassetti SA et al. Gabapentinin idiopathic trigeminal neuralgia. Neurology 50, A379 (1998) (Abstract).
   Web of Science ®Google Scholar
• Cheshire WP. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J. Pain 3, 137–142 (2002).
   PubMed Web of Science ®Google Scholar
• Zvartau-Hind M, Din MU, Gilani A, Lisak RP, Khan OA. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 55(10), 1587–1588 (2000).
   PubMed Web of Science ®Google Scholar
• Solaro C, Uccelli MM, Brichetto G, Gaspperini C, Mancardi G. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J. Pain Symptom Manage. 21(5), 367–368 (2001).
   PubMed Web of Science ®Google Scholar